CLINICAL_TRIALS
trial_result
· 2021-02-21
Clinical Trial Update: A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy [Phase 2]
Summary
Phase 2 trial of MNK-1411 in Duchenne Muscular Dystrophy was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mallinckrodt ARD LLC | Conditions: Muscular Dystrophy, Duchenne | Phase 2 | Status: TERMINATED | Results posted: 2021-02-21